# Ablative tReatment of Inoperable REnal Cell Carcinoma Using STereotactic Body Radiotherapy (ARREST-study)

> **NCT02853162** · PHASE2 · TERMINATED · sponsor: **UMC Utrecht** · enrollment: 30 (estimated)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **RADIATION:** ARREST-study

## Key facts

- **NCT ID:** NCT02853162
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-06
- **Primary completion:** 2020-04
- **Final completion:** 2020-04
- **Target enrollment:** 30 (ESTIMATED)
- **Why stopped:** Slow inclusion
- **Last updated:** 2021-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02853162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02853162, "Ablative tReatment of Inoperable REnal Cell Carcinoma Using STereotactic Body Radiotherapy (ARREST-study)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02853162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*